Authors:
MAAS JJ
DUKERS N
KROL A
VANAMEIJDEN EJC
VANLEEUWEN R
ROOS MTL
DEWOLF F
COUTINHO RA
KEET IPM
Citation: Jj. Maas et al., BODY-MASS INDEX COURSE IN ASYMPTOMATIC HIV-INFECTED HOMOSEXUAL MEN AND THE PREDICTIVE VALUE OF A DECREASE OF BODY-MASS INDEX FOR PROGRESSION TO AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(3), 1998, pp. 254-259
Authors:
ARBISER JL
KRAEFT SK
VANLEEUWEN R
HURWITZ SJ
SELIG M
DICKERSIN GR
FLINT A
BYERS HR
CHEN LB
Citation: Jl. Arbiser et al., CLIOQUINOL-ZINC CHELATE - A CANDIDATE CAUSATIVE AGENT OF SUBACUTE MYELO-OPTIC NEUROPATHY, Molecular medicine (Cambridge, Mass.), 4(10), 1998, pp. 665-670
Citation: Dg. Lappas et R. Vanleeuwen, ELECTRON CORRELATION-EFFECTS IN THE DOUBLE-IONIZATION OF HE, Journal of physics. B, Atomic molecular and optical physics, 31(6), 1998, pp. 249-256
Authors:
WIT FWNM
SOL CJA
RENWICK N
ROOS MTL
PALS ST
VANLEEUWEN R
GOUDSMIT J
REISS P
Citation: Fwnm. Wit et al., REGRESSION OF AIDS-RELATED KAPOSIS-SARCOMA ASSOCIATED WITH CLEARANCE OF HUMAN-HERPESVIRUS-8 FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS FOLLOWING INITIATION OF ANTIRETROVIRAL THERAPY, AIDS, 12(2), 1998, pp. 218-219
Authors:
MASS J
HUSMAN AMD
BROUWER M
KROL A
COUTINHO R
KEET I
VANLEEUWEN R
SCHUITEMAKER H
Citation: J. Mass et al., PRESENCE OF THE VARIANT MANNOSE-BINDING LECTIN ALLELES ASSOCIATED WITH SLOWER PROGRESSION TO AIDS, AIDS, 12(17), 1998, pp. 2275-2280
Authors:
WOUT ABVT
RAN LJ
NIJHUIS M
TIJNAGEL JMGH
DEGROOT T
VANLEEUWEN R
BOUCHER CAB
SCHUITEMAKER H
SCHUURMAN R
Citation: Abvt. Wout et al., EFFICIENT INHIBITION OF BOTH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING WILD-TYPE HIV-1 BY LAMIVUDINE IN-VIVO, AIDS, 12(10), 1998, pp. 1169-1176
Authors:
FOUDRAINE NA
WEVERLING GJ
VANGOOL T
ROOS MTL
DEWOLF F
KOOPMANS PP
VANDENBROEK PJ
MEENHORST PL
VANLEEUWEN R
LANGE JMA
REISS P
Citation: Na. Foudraine et al., IMPROVEMENT OF CHRONIC DIARRHEA IN PATIENTS WITH ADVANCED HIV-1 INFECTION DURING POTENT ANTIRETROVIRAL THERAPY, AIDS, 12(1), 1998, pp. 35-41
Authors:
REIJERS MHE
WEVERLING GJ
JURRIAANS S
WIT FWNM
WEIGEL HM
TENKATE RW
MULDER JW
FRISSEN PHJ
VANLEEUWEN R
REISS P
SCHUITEMAKER H
DEWOLF F
LANGE JMA
Citation: Mhe. Reijers et al., MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY, Lancet, 352(9123), 1998, pp. 185-190
Authors:
VANLEEUWEN R
SANTORO M
BRANNAGAN TH
LEE G
LATOV N
Citation: R. Vanleeuwen et al., ANTI-GALACTOCEREBROSIDE ANTIBODY WHICH BLOCKS HIV-1 GP120 BINDING REACTS WITH CLATHRIN IN NEURONAL CELLS, Neurology, 50(4), 1998, pp. 1055-1055
Authors:
MOODLEY J
MOODLEY D
PILLAY K
COOVADIA H
SABA J
VANLEEUWEN R
GOODWIN C
HARRIGAN PR
MOORE KHP
STONE C
PLUMB R
JOHNSON MA
Citation: J. Moodley et al., PHARMACOKINETICS AND ANTIRETROVIRAL ACTIVITY OF LAMIVUDINE ALONE OR WHEN COADMINISTERED WITH ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PREGNANT-WOMEN AND THEIR OFFSPRING, The Journal of infectious diseases, 178(5), 1998, pp. 1327-1333
Authors:
PAKKER NG
ROOS MTL
VANLEEUWEN R
DEJONG MD
KOOT M
REISS P
LANGE JMA
MIEDEMA F
DANNER SA
SCHELLEKENS PTA
Citation: Ng. Pakker et al., PATTERNS OF T-CELL REPOPULATION, VIRUS LOAD REDUCTION, AND RESTORATION OF T-CELL FUNCTION IN HIV-INFECTED PERSONS DURING THERAPY WITH DIFFERENT ANTIRETROVIRAL AGENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 16(5), 1997, pp. 318-326
Citation: R. Vanleeuwen, THE MAGPIE AND THE CAGE - NEW ESSAYS ON H ISTORIOGRAPHY - DUTCH - TOLLEBEEK,J, Tijdschrift voor geschiedenis, 110(3), 1997, pp. 358-361
Citation: R. Vanleeuwen, EVERY TIME IS A TIME OF TRANSITION - ESSA YS ON OUR HANDLING OF HISTORY - DUTCH - VONDERDUNK,HW, Tijdschrift voor geschiedenis, 110(3), 1997, pp. 358-361
Citation: R. Vanleeuwen, TRANSITORINESS AND CONTINUITY - ESSAYS ON HISTORY - DUTCH - KOSSMANN,EH, Tijdschrift voor geschiedenis, 110(3), 1997, pp. 358-361
Authors:
DZOLJIC E
VANLEEUWEN R
DEVRIES R
DZOLJIC MR
Citation: E. Dzoljic et al., VIGILANCE AND EEG POWER IN RATS - EFFECTS OF POTENT INHIBITORS OF THENEURONAL NITRIC-OXIDE SYNTHASE, Naunyn-Schmiedeberg's archives of pharmacology, 356(1), 1997, pp. 56-61
Authors:
STILIANAKIS NI
BOUCHER CAB
DEJONG MD
VANLEEUWEN R
SCHUURMAN R
DEBOER RJ
Citation: Ni. Stilianakis et al., CLINICAL-DATA SETS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASE-RESISTANT MUTANTS EXPLAINED BY A MATHEMATICAL-MODEL, Journal of virology, 71(1), 1997, pp. 161-168
Authors:
NIJHUIS M
SCHUURMAN R
DEJONG D
VANLEEUWEN R
LANGE J
DANNER S
KEULEN W
DEGROOT T
BOUCHER CAB
Citation: M. Nijhuis et al., LAMIVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS (184V) REQUIRE MULTIPLE AMINO-ACID CHANGES TO BECOME CO-RESISTANT TO ZIDOVUDINE IN-VIVO, The Journal of infectious diseases, 176(2), 1997, pp. 398-405
Authors:
VANLEEUWEN R
BONSEL GJ
REISS P
DANNER SA
LANGE JMA
Citation: R. Vanleeuwen et al., ADDITIVE OR SEQUENTIAL NUCLEOSIDE ANALOG THERAPY COMPARED WITH CONTINUED ZIDOVUDINE MONOTHERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH ADVANCED DISEASE DOES NOT PROLONG SURVIVAL - AN OBSERVATIONAL STUDY, The Journal of infectious diseases, 175(6), 1997, pp. 1344-1351
Authors:
VANTWOUT AB
RAN LJ
DEJONG MD
BAKKER M
VANLEEUWEN R
NOTERMANS DW
LOELIGER AE
DEWOLF F
DANNER SA
REISS P
BOUCHER CAB
LANGE JMA
SCHUITEMAKER H
Citation: Ab. Vantwout et al., SELECTIVE-INHIBITION OF SYNCYTIUM-INDUCING AND NONSYNCYTIUM-INDUCING HIV-1 VARIANTS IN INDIVIDUALS RECEIVING DIDANOSINE OR ZIDOVUDINE, RESPECTIVELY, The Journal of clinical investigation, 100(9), 1997, pp. 2325-2332
Citation: Ov. Gritsenko et al., DIRECT APPROXIMATION OF THE LONG-RANGE AND SHORT-RANGE COMPONENTS OF THE EXCHANGE-CORRELATION KOHN-SHAM POTENTIAL, International journal of quantum chemistry, 61(2), 1997, pp. 231-243
Authors:
VANLEEUWEN R
AYMAR M
UBACHS W
HOGERVORST W
Citation: R. Vanleeuwen et al., CHANNEL MIXING IN 4FNG AUTOIONIZING SERIES OF BARIUM, Journal of physics. B, Atomic molecular and optical physics, 29(5), 1996, pp. 1007-1023
Citation: Dw. Notermans et al., TREATMENT OF HIV-INFECTION - TOLERABILITY OF COMMONLY USED ANTIRETROVIRAL AGENTS, Drug safety, 15(3), 1996, pp. 176-187